Patsnap Lifescience Disease Investigationv0.1.0

A pharmaceutical R&D team uses the skill to evaluate the competitive landscape for a specific disease, including current SoC, ongoing clinical trials, and patent landscapes. This helps decide whether to enter a therapeutic area and identify unmet medical needs.

IP analysts leverage the skill to investigate patent landscapes around key targets (e.g., PD-1/PD-L1) and identify freedom-to-operate issues, enabling strategic patent filing or licensing decisions.

Business development teams use the skill to identify potential licensing or collaboration opportunities by analyzing clinical trial pipelines, deal intelligence, and market dynamics in specific regions (e.g., ADC deals in China).

Market access teams investigate disease incidence, patient demographics, and regional variations to estimate patient populations and market potential, supporting indication prioritization for drug development.

Clinical development teams leverage the skill to analyze current SoC efficacy/safety data and ongoing trials, informing the design of new clinical studies (e.g., choice of endpoints like PFS, ORR) and benchmarking against competitors.

Offer access to the skill as part of a broader platform that provides on-demand disease intelligence, with tiered subscriptions based on query volume and data breadth.

Use the skill to generate tailored disease investigation reports for clients (e.g., biotech startups, investment firms), charging per report or as part of a retainer.

Integrate the skill into pharmaceutical companies' internal knowledge management systems, licensing it as a module that augments existing analytics pipelines.